800
Participants
Start Date
October 10, 2025
Primary Completion Date
April 1, 2027
Study Completion Date
April 1, 2027
(IRIS-CKD Screening Program): Home Kit
"All participants approached for enrollment in Program 1 will receive National Kidney Foundational educational materials related to CKD screening in type 2 diabetes and study information. All enrolled participants will receive a message regarding study lab(s) results.~Home Test Kit: a kit delivered to participants homes with instructions to complete eGFR (fingerstick) and/or UACR (urine sample) testing, depending on which lab(s) are missing at baseline."
(IRIS-CKD Screening Program): Standard Lab Order
ll participants approached for enrollment in Program 1 will receive National Kidney Foundation educational materials related to CKD screening in type 2 diabetes and study information. All enrolled participants will receive a message regarding study lab
Duke University, Durham
Vanderbilt University Medical Center, Nashville
Essentia Health, Duluth
Ochsner, New Orleans
Baylor Scott & White, Temple
Intermountain Health, Murray
Lead Sponsor
Collaborators (2)
Bayer
INDUSTRY
Boehringer Ingelheim
INDUSTRY
Eli Lilly and Company
INDUSTRY
Duke University
OTHER